Evidence map›Paper›PMID 35643973›Full record

ArticleActas espanolas de psiquiatria2022

Ketamine for resistant depression: a scoping review.

Tuta-Quintero Eduardo, Acero Angela, León Mateo, López-Zuleta Melanie, Prieto-Fernández Valentina, Charry David, Collazos Estefania, Rojas-Sanchez Natalia, Vargas-Camacho Andrés, Rodríguez-Olarte Angel and 2 more

Abstract readScoping Review
In one paragraph

Article in Actas espanolas de psiquiatria, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Ketamine - An Imperfect Wonder Drug?Biochemical pharmacology · 2024
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tuta-Quintero EduardoMedicine School, Universidad de La Sabana, Chía, Colombia.
Acero AngelaMedicine School, Universidad de La Sabana, Chía, Colombia.
León MateoMedicine School, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia.
López-Zuleta MelanieMedicine School, Universidad del Norte, Barranquilla, Colombia.
Prieto-Fernández ValentinaMedicine School, Universidad del Norte, Barranquilla, Colombia.
Charry DavidMedicine School, Universidad de La Sabana, Chía, Colombia.
Collazos EstefaniaMedicine School, Universidad de La Sabana, Chía, Colombia.
Rojas-Sanchez NataliaMedicine School, Fundación Universitaria Juan N Corpas, Bogotá, Colombia.
Vargas-Camacho AndrésInternal Medicine Program, Universidad de Autónoma de Bucaramanga,Colombia.
Rodríguez-Olarte AngelMedicine School, Universidad del Rosario, Bogotá, Colombia.
Guerrero JuanMedicine School, Universidad de La Sabana, Chía, Colombia.
Pimentel JuanMedicine School, Universidad de La Sabana, Chía, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ketamine is a fast-acting anesthetic with hypnotic properties. Moreover, could potentially improve affective symptoms in patients with refractory depressive disorder. Objective. explore the scientific literature available until December 10, 2021, about the efficacy and safety of ketamine in patients with treatment-refractory major depressive disorder. Material and methods. Scoping review that included PubMed and Scopus. Records of clinical trials and publications with empirical data in English and Spanish were included.

Indexed as

KetamineMajor Depressive DisorderAntidepressive AgentsDepressionHumansAntidepressive AgentsKetamine

Identifiers

PMID35643973
PMCPMC10803828

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.